1Life Healthcare, Inc. (NASDAQ:ONEM) CTO Sells $501,300.00 in Stock

1Life Healthcare, Inc. (NASDAQ:ONEM) CTO Kimber D. Lockhart sold 15,000 shares of 1Life Healthcare stock in a transaction dated Wednesday, November 18th. The shares were sold at an average price of $33.42, for a total value of $501,300.00. Following the sale, the chief technology officer now owns 52,349 shares of the company’s stock, valued at $1,749,503.58. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink.

Kimber D. Lockhart also recently made the following trade(s):

  • On Wednesday, September 16th, Kimber D. Lockhart sold 15,000 shares of 1Life Healthcare stock. The shares were sold at an average price of $29.31, for a total value of $439,650.00.

Shares of NASDAQ ONEM opened at $35.44 on Friday. The company has a quick ratio of 7.47, a current ratio of 7.50 and a debt-to-equity ratio of 0.45. The business’s 50 day moving average is $30.98 and its two-hundred day moving average is $31.54. The company has a market cap of $4.71 billion and a P/E ratio of -12.48. 1Life Healthcare, Inc. has a 12 month low of $15.00 and a 12 month high of $44.87.

1Life Healthcare (NASDAQ:ONEM) last released its quarterly earnings data on Sunday, November 15th. The company reported ($0.13) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.19) by $0.06. The firm had revenue of $101.67 million for the quarter, compared to the consensus estimate of $86.16 million. The business’s revenue for the quarter was up 46.0% on a year-over-year basis. During the same quarter in the prior year, the firm posted ($0.82) earnings per share. Sell-side analysts expect that 1Life Healthcare, Inc. will post -0.91 earnings per share for the current fiscal year.

Several equities research analysts recently weighed in on ONEM shares. Piper Sandler boosted their target price on 1Life Healthcare from $43.00 to $44.00 and gave the stock an “overweight” rating in a report on Wednesday, November 11th. Morgan Stanley boosted their target price on 1Life Healthcare from $35.00 to $41.00 and gave the stock an “overweight” rating in a report on Wednesday, November 11th. Smith Barney Citigroup boosted their target price on 1Life Healthcare from $38.00 to $42.00 in a report on Wednesday, November 11th. SVB Leerink boosted their target price on 1Life Healthcare from $36.00 to $38.00 and gave the stock a “market perform” rating in a report on Wednesday, November 11th. Finally, Wells Fargo & Company boosted their target price on 1Life Healthcare from $23.00 to $28.00 and gave the stock an “equal weight” rating in a report on Thursday, August 13th. Five analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. 1Life Healthcare currently has a consensus rating of “Buy” and an average target price of $37.43.

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Zurcher Kantonalbank Zurich Cantonalbank bought a new stake in shares of 1Life Healthcare during the second quarter valued at approximately $35,000. Great West Life Assurance Co. Can acquired a new stake in 1Life Healthcare in the 2nd quarter valued at $61,000. Steward Partners Investment Advisory LLC acquired a new position in 1Life Healthcare in the third quarter worth $55,000. CWM LLC acquired a new position in 1Life Healthcare in the second quarter worth $73,000. Finally, Zurcher Kantonalbank Zurich Cantonalbank boosted its stake in 1Life Healthcare by 126.7% in the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,160 shares of the company’s stock worth $61,000 after purchasing an additional 1,207 shares in the last quarter. Institutional investors and hedge funds own 65.25% of the company’s stock.

1Life Healthcare Company Profile

1Life Healthcare, Inc operates a membership-based primary care platform. The company has developed a healthcare membership model based on direct consumer enrollment, as well as employer sponsorship. Its membership model includes seamless access to digital health services paired with inviting in-office care routinely covered under health insurance programs.

See Also: What are gap-down stocks?

Insider Buying and Selling by Quarter for 1Life Healthcare (NASDAQ:ONEM)

Receive News & Ratings for 1Life Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 1Life Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.